STRATA Skin Sciences, Inc. (SSKN)
NASDAQ: SSKN · Real-Time Price · USD
1.330
-0.030 (-2.21%)
At close: Dec 16, 2025, 4:00 PM EST
1.351
+0.021 (1.60%)
After-hours: Dec 16, 2025, 5:21 PM EST
STRATA Skin Sciences Market Cap
STRATA Skin Sciences has a market cap or net worth of $7.89 million as of December 16, 2025. Its market cap has decreased by -37.40% in one year.
Market Cap
7.89M
Enterprise Value
17.24M
1-Year Change
-37.40%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since November 3, 2005, STRATA Skin Sciences's market cap has decreased from $53.80M to $7.89M, a decrease of -85.34%. That is a compound annual growth rate of -9.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 8.00M | -33.88% |
| Dec 31, 2024 | 12.10M | -37.31% |
| Dec 29, 2023 | 19.30M | -29.56% |
| Dec 30, 2022 | 27.40M | -45.53% |
| Dec 31, 2021 | 50.30M | -0.79% |
| Dec 31, 2020 | 50.70M | -25.88% |
| Dec 31, 2019 | 68.40M | -12.20% |
| Dec 31, 2018 | 77.90M | 1,458.00% |
| Dec 29, 2017 | 5.00M | 6.38% |
| Dec 30, 2016 | 4.70M | -58.41% |
| Dec 31, 2015 | 11.30M | 56.94% |
| Dec 31, 2014 | 7.20M | -76.24% |
| Dec 31, 2013 | 30.30M | -46.47% |
| Dec 31, 2012 | 56.60M | -39.27% |
| Dec 30, 2011 | 93.20M | 10.17% |
| Dec 31, 2010 | 84.60M | -63.12% |
| Dec 31, 2009 | 229.40M | 288.16% |
| Dec 31, 2008 | 59.10M | -14.96% |
| Dec 31, 2007 | 69.50M | -27.30% |
| Dec 29, 2006 | 95.60M | 66.26% |
| Dec 30, 2005 | 57.50M | 6.88% |
| Nov 3, 2005 | 53.80M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |